Genmab — Oktober 2022
-
Aktier/tendens: Vestas i fokus før ventet rød start på fjerde kvartal https://www.proinvestor.com/investornyt/885620/aktier-tendens-vestas-i-fokus-for-ventet-rod-start-pa-fjerde-kvartal
-
Congress | #SOHO22 Alex Herrera from
@cityofhope
presents updated results from a phase II study where camidanlumab tesirine demonstrated an ORR of 70.1%, median DOR of 13.7 months and median PFS of 9.1 months in patients with R/R CHL https://twitter.com/lymphomahub/status/1575986164598964224 -
ADC Offers Promising Results in Relapsed or Refractory... https://www.medpagetoday.com/meetingcoverage/soho/101011
-
Teclistamab Shows Promise for People with Heavily Pretreated Multiple Myeloma https://www.cancer.gov/news-events/cancer-currents-blog/2022/tecvayli-multiple-myeloma
-
Oxford BioTherapeutics enters into Commercial License Agreement with Genmab https://www.prnewswire.com/news-releases/oxford-biotherapeutics-enters-into-commercial-license-agreement-with-genmab-301638067.html
-
Hvorfor egenligt det?
-
Det er vi enige om gdn55.
-
Der var faktisk en lille nyhed i eftermiddags: Oxford, UK and San Jose, California, 3 October 2022 - Oxford BioTherapeutics (OBT), a clinical
stage oncology company with a pipeline of immuno-oncology (IO) and antibody drug conjugate
(ADC)-based therapies, today announced that global oncology leader, Genmab has licensed a
novel antibody related to one of OBT’s IO programs. -
Godmorgen.
-
Gentogen.. Vi havde den her,
Genmab indgår aftale om kommercialisering af antistof fra Oxford Bio https://www.proinvestor.com/investornyt/885745/genmab-indgar-aftale-om-kommercialisering-af-antistof-fra-oxford-bio -
Normalt ikke noget som er kursdrivende.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind